Activity of Cefiderocol and Comparators against Isolates from Cancer Patients. 2020

Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
Department of Infectious Diseases, Infection Control, and Employee Health, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA krolston@mdanderson.org.

Cefiderocol inhibited 97.5% of 478 Gram-negative isolates from cancer patients at ≤4 mg/liter. It had potent activity against extended-spectrum β-lactamase-positive Enterobacteriaceae, carbapenem-resistant Enterobacteriaceae (CRE), and nonfermenting Gram-negative bacilli, including Pseudomonas aeruginosa, Stenotrophomonas maltophilia, and Acinetobacter species isolates. Amikacin, ceftazidime-avibactam, and meropenem had appreciable activity against non-CRE Enterobacteriaceae No comparators were active against multidrug-resistant P. aeruginosa isolates. Only trimethoprim-sulfamethoxazole had appreciable activity against S. maltophilia isolates. Overall, cefiderocol was associated with the lowest level of resistance.

UI MeSH Term Description Entries
D008826 Microbial Sensitivity Tests Any tests that demonstrate the relative efficacy of different chemotherapeutic agents against specific microorganisms (i.e., bacteria, fungi, viruses). Bacterial Sensitivity Tests,Drug Sensitivity Assay, Microbial,Minimum Inhibitory Concentration,Antibacterial Susceptibility Breakpoint Determination,Antibiogram,Antimicrobial Susceptibility Breakpoint Determination,Bacterial Sensitivity Test,Breakpoint Determination, Antibacterial Susceptibility,Breakpoint Determination, Antimicrobial Susceptibility,Fungal Drug Sensitivity Tests,Fungus Drug Sensitivity Tests,Sensitivity Test, Bacterial,Sensitivity Tests, Bacterial,Test, Bacterial Sensitivity,Tests, Bacterial Sensitivity,Viral Drug Sensitivity Tests,Virus Drug Sensitivity Tests,Antibiograms,Concentration, Minimum Inhibitory,Concentrations, Minimum Inhibitory,Inhibitory Concentration, Minimum,Inhibitory Concentrations, Minimum,Microbial Sensitivity Test,Minimum Inhibitory Concentrations,Sensitivity Test, Microbial,Sensitivity Tests, Microbial,Test, Microbial Sensitivity,Tests, Microbial Sensitivity
D009369 Neoplasms New abnormal growth of tissue. Malignant neoplasms show a greater degree of anaplasia and have the properties of invasion and metastasis, compared to benign neoplasms. Benign Neoplasm,Cancer,Malignant Neoplasm,Tumor,Tumors,Benign Neoplasms,Malignancy,Malignant Neoplasms,Neoplasia,Neoplasm,Neoplasms, Benign,Cancers,Malignancies,Neoplasias,Neoplasm, Benign,Neoplasm, Malignant,Neoplasms, Malignant
D011550 Pseudomonas aeruginosa A species of gram-negative, aerobic, rod-shaped bacteria commonly isolated from clinical specimens (wound, burn, and urinary tract infections). It is also found widely distributed in soil and water. P. aeruginosa is a major agent of nosocomial infection. Bacillus aeruginosus,Bacillus pyocyaneus,Bacterium aeruginosum,Bacterium pyocyaneum,Micrococcus pyocyaneus,Pseudomonas polycolor,Pseudomonas pyocyanea
D002442 Ceftazidime Semisynthetic, broad-spectrum antibacterial derived from CEPHALORIDINE and used especially for Pseudomonas and other gram-negative infections in debilitated patients. Ceftazidime Anhydrous,Ceftazidime Pentahydrate,Fortaz,Fortum,GR-20263,LY-139381,Pyridinium, 1-((7-(((2-amino-4-thiazolyl)((1-carboxy-1-methylethoxy)imino)acetyl)amino)-2-carboxy-8-oxo-5-thia-1-azabicyclo(4.2.0)oct-2-en-3-yl)methyl)-, inner salt, pentahydrate, (6R-(6alpha,7beta(Z)))-,Tazidime,GR 20263,GR20263,LY 139381,LY139381
D002511 Cephalosporins A group of broad-spectrum antibiotics first isolated from the Mediterranean fungus ACREMONIUM. They contain the beta-lactam moiety thia-azabicyclo-octenecarboxylic acid also called 7-aminocephalosporanic acid. Antibiotics, Cephalosporin,Cephalosporanic Acid,Cephalosporin,Cephalosporin Antibiotic,Cephalosporanic Acids,Acid, Cephalosporanic,Acids, Cephalosporanic,Antibiotic, Cephalosporin,Cephalosporin Antibiotics
D004338 Drug Combinations Single preparations containing two or more active agents, for the purpose of their concurrent administration as a fixed dose mixture. Drug Combination,Combination, Drug,Combinations, Drug
D006090 Gram-Negative Bacteria Bacteria which lose crystal violet stain but are stained pink when treated by Gram's method. Gram Negative Bacteria
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man
D000073182 Carbapenem-Resistant Enterobacteriaceae Strains of Enterobacteriaceae that are resistant to CARBAPENEMS, primarily due to the acquisition of carbapenemase (BETA-LACTAMASE) genes. Carbapenemase-Producing Enterobacteriaceae
D000077731 Meropenem A thienamycin derivative antibacterial agent that is more stable to renal dehydropeptidase I than IMIPENEM, but does not need to be given with an enzyme inhibitor such as CILASTATIN. It is used in the treatment of bacterial infections, including infections in immunocompromised patients. 3-(5-Dimethylcarbamoylpyrrolidin-3-ylthio)-6-(1-hydroxyethyl)-4-methyl-7-oxo-1-azabicyclo(3.2.0)hept-2-ene-2-carboxylic acid,Merrem,Penem,Ronem,SM 7338,SM-7338,SM7338

Related Publications

Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
December 2021, Journal of global antimicrobial resistance,
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
September 2023, Microbiology spectrum,
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
October 2022, Antibiotics (Basel, Switzerland),
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
November 2023, Journal of chemotherapy (Florence, Italy),
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
March 2019, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
March 2009, International journal of infectious diseases : IJID : official publication of the International Society for Infectious Diseases,
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
January 2022, Antibiotics (Basel, Switzerland),
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
August 2010, European journal of clinical microbiology & infectious diseases : official publication of the European Society of Clinical Microbiology,
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
September 2021, Journal of global antimicrobial resistance,
Kenneth V I Rolston, and Baghat Gerges, and Samuel Shelburne, and Samuel L Aitken, and Issam Raad, and Randall A Prince
June 2021, JAC-antimicrobial resistance,
Copied contents to your clipboard!